Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CV Sciences Eagerly Anticipating FDA Rulemaking On CBD In Dietary Supplements

May 01 2020

• By Ryan Nelson

CBD Molecule

Related Content

FDA Warns 15 CBD Product Marketers For Violations, Cautions Consumers: CBD May Harm You

Nov 27 2019

CBD Format – Spectrum Or Isolate? – Likely To Be Differentiator Tried In FDA Forum, Courts

Mar 26 2020

FDA's CBD Enforcement Policy Report To Congress May Have Offered More Questions Than Answers

Mar 17 2020

FDA Action Items For CBD Policy? The List Is Short Due To 'Critical' Data Gaps

Jan 20 2020

Federal Court Stays Class Action Against CBD Firm Green Roads To Await FDA Rulemaking

Jan 17 2020

Future Of CBD In Supplements: NDI Notification Looms As Regulatory Path

Dec 03 2019

Additional Topics

United States Regulation Dietary Supplements Ingredients FDA Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window